Literature DB >> 7650492

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

D Arnold1, S Faath, H Rammensee, H Schild.   

Abstract

Vaccination of mice with heat shock proteins isolated from tumor cells induces immunity to subsequent challenge with those tumor cells the heat shock protein was isolated from but not with other tumor cells (Udono, H., and P.K. Srivastava. 1994. J. Immunol. 152:5398-5403). The specificity of this immune response is caused by tumor-derived peptides bound to the heat shock proteins (Udono., H., and P.K. Srivastava. 1993. J. Exp. Med. 178:1391-1396). Our experiments show that a single immunization with the heat shock protein gp96 isolated from beta-galactosidase (beta-gal) expressing P815 cells (of DBA/2 origin) induces cytotoxic T lymphocytes (CTLs) specific for beta-gal, in addition to minor H antigens expressed by these cells. CTLs can be induced in mice that are major histocompatibility complex (MHC) identical to the gp96 donor cells (H-2d) as well as in mice with a different MHC (H-2b). Thus gp96 is able to induce "cross priming" (Matzinger, P., and M.J. Bevan. 1977. Cell. Immunol. 33:92-100), indicating that gp96-associated peptides are not limited to the MHC class I ligands of the gp96 donor cell. Our data confirm the notion that samples of all cellular antigens presentable by MHC class I molecules are represented by peptides associated with gp96 molecules of that cell, even if the fitting MHC molecule is not expressed. In addition, we extend previous reports on the in vivo immunogenicity of peptides associated gp96 molecules to two new groups of antigens, minor H antigens, and proteins expressed in the cytosol.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650492      PMCID: PMC2192175          DOI: 10.1084/jem.182.3.885

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Proteasomes are regulated by interferon gamma: implications for antigen processing.

Authors:  Y Yang; J B Waters; K Früh; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 2.  Peptides naturally presented by MHC class I molecules.

Authors:  H G Rammensee; K Falk; O Rötzschke
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

3.  Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.

Authors:  H Udono; P K Srivastava
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

4.  Heat shock protein vaccines against cancer.

Authors:  N E Blachere; H Udono; S Janetzki; Z Li; M Heike; P K Srivastava
Journal:  J Immunother Emphasis Tumor Immunol       Date:  1993-11

5.  Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.

Authors:  H Udono; D L Levey; P K Srivastava
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

6.  Peptide size selection by the major histocompatibility complex-encoded peptide transporter.

Authors:  F Momburg; J Roelse; G J Hämmerling; J J Neefjes
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

7.  Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.

Authors:  M A Gavin; M J Gilbert; S R Riddell; P D Greenberg; M J Bevan
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

8.  Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.

Authors:  Z Li; P K Srivastava
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

9.  Heat shock protein 70-associated peptides elicit specific cancer immunity.

Authors:  H Udono; P K Srivastava
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

10.  Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide.

Authors:  H Schild; M Norda; K Deres; K Falk; O Rötzschke; K H Wiesmüller; G Jung; H G Rammensee
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

View more
  54 in total

Review 1.  Heat shock proteins: the fountainhead of innate and adaptive immune responses.

Authors:  S Basu; P K Srivastava
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

Review 2.  The heat shock protein gp96: a receptor-targeted cross-priming carrier and activator of dendritic cells.

Authors:  H Singh-Jasuja; N Hilf; H U Scherer; D Arnold-Schild; H G Rammensee; R E Toes; H Schild
Journal:  Cell Stress Chaperones       Date:  2000-11       Impact factor: 3.667

3.  gp96-peptide vaccination of mice against intracellular bacteria.

Authors:  U Zügel; A M Sponaas; J Neckermann; B Schoel; S H Kaufmann
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

4.  Heat shock proteins refine the danger theory.

Authors:  S M Todryk; A A Melcher; A G Dalgleish; R G Vile
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

Review 5.  Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come.

Authors:  Ayesha Murshid; Jianlin Gong; Mary Ann Stevenson; Stuart K Calderwood
Journal:  Expert Rev Vaccines       Date:  2011-11       Impact factor: 5.217

Review 6.  Class I MHC presentation of exogenous antigens.

Authors:  C V Harding
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

7.  Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Authors:  Robert G Newman; Michael J Dee; Thomas R Malek; Eckhard R Podack; Robert B Levy
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

8.  Increased proteolysis of diphtheria toxin by human monocytes after heat shock: a subsidiary role for heat-shock protein 70 in antigen processing.

Authors:  Barbara S Polla; Françoise Gabert; Brigitte M-N Peyrusse; Muriel R Jacquier-Sarlin
Journal:  Immunology       Date:  2006-11-20       Impact factor: 7.397

9.  Carbonic anhydrase IX has chaperone-like functions and is an immunoadjuvant.

Authors:  Yanping Wang; Xiang-Yang Wang; John R Subjeck; Hyung L Kim
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

Review 10.  Functions of heat shock proteins in pathways of the innate and adaptive immune system.

Authors:  Robert Julian Binder
Journal:  J Immunol       Date:  2014-12-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.